Xeris Biopharma Holdings, Inc. (XERS)
Latest XERS Insider Trades
About Xeris Biopharma Holdings, Inc. (XERS)
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
- CHICAGO, IL
- 435
- 2018
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 12 | 271,499 | $2.04M |
| Grant or award | 14 | 414,626 | |
| Tax withholding / forfeiture | 2 | 58,563 |
XERS Insider Transactions (Form 4)
1642 Form 4 filings on record, the earliest from Nov 26, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Beth Hecht - Officer | Open-market sale | Common Stock | 16,667 |
Recent XERS Form 8-K Filings
5Recent XERS Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| STEVEN PIEPER | Officer | 20,000 | $168K | View on EDGAR | |
| - | - |
XERS Insider Trading - FAQ
What is the latest insider trade for XERS?
Xeris Biopharma Holdings, Inc. (XERS) had 16 insider filings in the last 90 days, with the most recent on 2026-08-21. The full record for XERS runs to 42 Form 4 filings, the earliest from 2024-11-26. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying XERS stock?
No insider purchases of XERS were filed in the last 90 days.
How many insiders are selling XERS stock?
12 insider sales of XERS were filed in the last 90 days, totaling $2.04M.
Where can I see XERS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks XERS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow XERS insider buys?
Create a free InsiderAlpha account and press Watch on this page to add XERS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - John Patrick Shannon Jr. view on EDGAR
- - Kevin McCulloch view on EDGAR
- - Steven Pieper view on EDGAR
- - Kevin McCulloch view on EDGAR
- - Beth Hecht view on EDGAR
- - Steven Pieper view on EDGAR
- - Nerissa Kreher view on EDGAR
- - Kevin McCulloch view on EDGAR
- - Beth Hecht view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where XERS's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track XERS insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
